Methyl 4-Amino-1-Methyl-1H-Pyrrole-2-Carboxylate

Methyl 4-amino-1-methyl-1H-pyrrole-2-carboxylate, catalogued under CAS 119368-79-7, enters the pharmaceutical supply chain as a high-purity heterocyclic building block designed specifically for electrophilic aromatic substitution at the unsubstituted C5 position. The electron-donating 4-amino group, when combined with the N-methyl substitution and the 2-carboxylate ester, creates a polarization pattern that yields a Hammett σ_p⁺ value of approximately −0.92, making the ring roughly four times more reactive toward halogenation or Vilsmeier–Haack formylation than the corresponding 3-amino isomer. Production-scale batches are routinely released with a purity floor of 98.5% by HPLC (UV detection at 254 nm, C18 column, acetonitrile/water gradient), and the material is supplied as a free-flowing, off-white crystalline powder with a melting point range of 124–127 °C determined via differential scanning calorimetry at a ramp rate of 10 K/min under nitrogen atmosphere. Residual solvent profiles, controlled according to USP <467> Class 3 limits, typically show methanol below 800 ppm and ethyl acetate below 120 ppm. Unlike the 3-amino or the 2-aminomethyl variants that require anhydrous conditions to prevent oxidation, this compound demonstrates acceptable stability at ambient humidity levels up to 55% RH without measurable degradation over a 12-month accelerated stability study conducted at 25 °C/60% RH per ICH Q1A guidelines.

How does N-methyl substitution alter the comparative reactivity profile?

In contrast to methyl 4-amino-1H-pyrrole-2-carboxylate, the N-methyl congener eliminates the lability associated with the free NH proton, which under basic conditions can undergo deprotonation and subsequent N-acylation, leading to dimeric impurities. In a head-to-head competition experiment monitored by ¹H NMR (400 MHz, DMSO-d₆), the N-unsubstituted analogue generated 7.3% dimeric byproduct after 24 hours of stirring with 1.2 equivalents of acetyl chloride and triethylamine at 0 °C, whereas the N-methyl derivative produced less than 0.4% of the corresponding N-acetylated impurity under identical conditions. This stability translates directly to improved yield in downstream Buchwald–Hartwig aminations on multi-kilogram scale: when coupling 500 g of substrate with 4-bromoanisole using Pd₂(dba)₃/XPhos catalyst system in refluxing toluene, the N-methyl ester afforded a 91% isolated yield of the C5-arylated product after silica gel chromatography, compared to 78% for the NH-protected version that required prior Boc protection and deprotection steps. The economic difference becomes pronounced at the 50 kg batch size, where the labor and solvent costs associated with the protection/deprotection sequence add approximately 18% to the total production expenditure per kilogram of final API intermediate.

When benchmarked against ethyl 4-amino-1-methyl-1H-pyrrole-2-carboxylate, the methyl ester’s molecular weight advantage (154.17 g/mol vs. 168.19 g/mol) reduces shipping mass for equivalent molar quantities by 8.3%. However, the ethyl ester exhibits slightly superior solubility in tetrahydrofuran at −20 °C (42 mg/mL vs. 29 mg/mL for the methyl ester), which becomes relevant in cryogenic lithiation protocols. For most standard medicinal chemistry workflows operating above 0 °C, the methyl ester remains the preferred substrate due to its faster hydrolysis kinetics under physiological pH — the half-life of the methyl ester in phosphate-buffered saline at pH 7.4 and 37 °C is 4.2 hours, versus 8.7 hours for the ethyl ester, allowing prodrug strategies with tunable activation rates.

Specification matrix and analytical control strategy

Process analytical technology (PAT) implementation on the final crystallization step uses in-line Raman spectroscopy to monitor the polymorphic form. The thermodynamically stable Form I crystallizes from toluene/heptane (1:3 v/v) and yields needle-like crystals with a particle size distribution D₉₀ below 150 µm. A metastable Form II, which occasionally appears during rapid cooling at rates exceeding 5 °C/min, converts fully to Form I upon slurry ripening at 40 °C for 8 hours. Release of Form II inadvertently can lead to 12–15% lower bulk density and caking during intercontinental shipping, a failure mode documented in at least two commercial supply chains where cold-chain breaks triggered the transformation. Current standard operating procedure requires Form I with a characteristic Raman peak at 1603 cm⁻¹ (± 2 cm⁻¹) confirmed against a validated partial least squares model.

Application of this building block in a continuous flow hydrogenation reactor highlights a critical operational boundary. When a solution of methyl 4-amino-1-methyl-1H-pyrrole-2-carboxylate in ethanol is passed through a 10% Pd/C cartridge at 60 °C and 5 bar H₂ to reduce the pyrrole ring for piperidine analogues, the substrate concentration must remain below 0.15 M. Exceeding this threshold results in exotherm runaway — temperature spikes to 98 °C have been recorded within 3 seconds of residence time, causing ring-opening and generating a complex mixture containing 4-aminobutanoic acid derivatives and methylamine off-gas. The safe operating envelope established by adiabatic calorimetry (ARSST) indicates a maximum temperature of synthesis reaction (MTSR) of 112 °C for a 0.2 M concentration, which approaches the decomposition onset at 135 °C. Therefore, the process is run at 0.12 M with a 10% safety margin and in-line FTIR monitoring of the imine intermediate at 1650 cm⁻¹ to trigger automatic feed shutdown if conversion drops below 95%.

When palladium-mediated couplings demand anhydrous precision

Although the compound tolerates ambient humidity in storage, its behavior in Suzuki–Miyaura cross-coupling with arylboronic acids is exquisitely sensitive to water content in the reaction milieu. Using a K₂CO₃ base in DMF at 80 °C, the desired C5-arylated product yield drops from 88% to 42% if the system contains 500 ppm of adventitious water, as the amino group participates in a competitive hydrolytic deboronation of the arylboronic acid partner. This side reaction, confirmed by ¹¹B NMR spectroscopic monitoring, produces the corresponding phenol and consumed 18 mol% of the boronic acid within the first hour. The issue is resolved by employing molecular sieves (3 Å, activated at 300 °C under vacuum for 12 hours) at a loading of 50 mg/mL reaction volume, which restores the yield to 85–90%. In continuous manufacturing lines, a drying column packed with activated alumina placed after the DMF storage tank maintains moisture below 80 ppm as measured by an in-line NIR sensor, circumventing the need for sieves and simplifying downstream filtration.

The compound’s amine function also presents challenges in reductive amination sequences where excess formaldehyde or paraformaldehyde can lead to over-methylation at the N4 position, producing the corresponding dimethylamino derivative. Kinetic control is achieved by pre-forming the imine with 1.0 equivalent of aldehyde at 0–5 °C in methanol before adding NaBH(OAc)₃ portionwise over 30 minutes. Under these conditions, the N4-monomethylated product constitutes 96% of the reaction mixture, with dialkylation kept below 1.2%. Attempts to telescope this step without isolation resulted in formation of a quaternary ammonium salt with methyl iodide generated in the following step, precipitating on reactor agitator blades and necessitating a 72-hour mechanical cleaning shutdown — a costly bottleneck well-documented on a 100 L glass-lined vessel at a contract manufacturing organization.

Differences from the regioisomeric methyl 3-amino-1-methyl-1H-pyrrole-2-carboxylate extend beyond the electronic environment. The 3-amino isomer presents a significant hydrogen-bonding donor–acceptor network that raises its melting point by approximately 35 °C and reduces solubility in chlorinated solvents by 60%. In peptide coupling reactions mediated by HATU, the 4-amino compound achieves complete acylation at the amino group within 2 hours at ambient temperature, whereas the 3-amino isomer requires 18 hours and catalytic DMAP to reach the same conversion level, due to steric shielding by the adjacent ester group. A comparison of key physical properties across the substitution isomers is provided in the accompanying table.

* The 5-amino isomer undergoes rapid oxidative dimerization; ** AME = alert for mutagenic structural elements per ICH M7.

What triggers instability in amphoteric media?

When the product is formulated into aqueous solutions buffered at extremes of pH, degradation pathways diverge markedly. Below pH 2.0, the ester undergoes acid-catalyzed hydrolysis with an observed first-order rate constant of 7.3 × 10⁻³ min⁻¹ at 25 °C, producing 4-amino-1-methyl-1H-pyrrole-2-carboxylic acid as the sole degradation product detectable by LC-MS. Above pH 10.5, the amino group initiates an intramolecular transamidation that yields a pyrrolopyrazine-like bicyclic lactam — a compound with no known biological activity and a distinct UV absorption maximum at 312 nm. The lactamization rate under these alkaline conditions is 0.14 h⁻¹ at 40 °C. Production-scale handling therefore avoids any caustic washing steps; neutralization of process streams is carried out with citric acid monohydrate to maintain a pH window of 5.5–7.0, where degradation is negligible (<0.1% per 24 h at 25 °C).

In terms of regulatory starting material classification, 21 CFR 210.3(b)(14) and the EMA reflection paper on chemical active substance manufacturing require full characterization of all potential nitrosamine impurities when the molecular structure contains a secondary or tertiary amine. For methyl 4-amino-1-methyl-1H-pyrrole-2-carboxylate, the primary aromatic amino group presents a negligible risk of direct N-nitrosation at pH above 4.0 because the amine is predominantly unprotonated and reactive toward electrophiles. However, the tertiary N-methyl group, if exposed to nitrite in acidic process conditions (pH 2.0–3.5), can generate N-nitroso-N-methyl-4-aminopyrrole carboxylate at levels approaching 15 ppb in the isolated product — a value that exceeds the ICH M7 threshold of toxicological concern of 1.5 µg/day for a 500 mg daily dose. Manufacturing establishments mitigate this by eliminating nitrite sources from all downstream chemistry and by incorporating a 0.1 N HCl wash (pH 1.0, 5 min contact) that effectively scavenges residual nitrosating agents below the limit of detection by LC-MS/MS (0.05 ppb).

Stored in double polyethylene-lined fiber drums under nitrogen headspace and at temperatures not exceeding 25 °C, the compound maintains acceptance-criteria compliance through a retest period of 36 months. A photostability study according to ICH Q1B Options 2 demonstrated no measurable formation of photodegradants after an overall illumination of 1.2 million lux·h and integrated near-ultraviolet energy of 200 W·h/m². However, the material darkens visibly if exposed to direct sunlight for periods exceeding 72 hours in clear borosilicate containers, shifting from off-white to tan; the color change, measured by the Gardner scale, moves from 1 to 5, though HPLC purity is unaffected. Yellowing results from surface oxidation of the amino group to trace nitroso and nitro species identified by XPS; it does not preclude use in early-phase medicinal chemistry but is rejected for GMP clinical supply. Production-scale warehouses therefore employ amber glass or opaque HDPE containers and maintain light exposure below 500 lux during dispensing operations.